Propylthiouracil for alcoholic liver disease (Q24236315)

4

0 references

Andrew Kenneth Burroughs

5

object named as

Andrew K Burroughs

0 references

author name string

Giuseppe Fede

1

0 references

Giacomo Germani

Cochrane Database of Systematic Reviews

2

0 references

publication date

15 June 2011

0 references

published in

0 references

cites work

Long-term treatment of alcoholic liver disease with propylthiouracil

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Long-term treatment of alcoholic liver disease with propylthiouracil. Part 2: Influence of drop-out rates and of continued alcohol consumption in a clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Vasodilatory effects of propylthiouracil in patients with alcoholic cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Acute effects of propylthiouracil on hemodynamics and oxygen content in patients with alcoholic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Attributable risk for symptomatic liver cirrhosis in Italy. Collaborative Groups for the Study of Liver Diseases in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Methods for combining randomized clinical trials: strengths and limitations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Acute interstitial nephritis and fatal Stevens-Johnson syndrome after propylthiouracil therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Assessment of risk of bias in randomized clinical trials in surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Antioxid ant activity of propylthiouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Propylthiouracil-induced severe hepatitis: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Experimental alcohol-induced hepatic necrosis: suppression by propylthiouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Clinical Pharmacokinetics of Antithyroid Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Effects of propylthiouracil and methimazole on splanchnic hemodynamics in awake and unrestrained rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Treatment of hyperthyroid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Alcoholic liver disease: new insights in pathogenesis lead to new treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

II. Veterans Affairs Cooperative Study of Polyenylphosphatidylcholine in Alcoholic Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Anti-thyroid drug-induced ANCA-associated vasculitis: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Anabolic-androgenic steroids for alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

S-adenosyl-L-methionine for alcoholic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Alcohol-induced hepatic injury in nonalcoholic volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: A multicenter sequential trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Do certain countries produce only positive results? A systematic review of controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Enhancement of hypoxic liver damage by ethanol. Involvement of xanthine oxidase and the role of glycolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Propylthiouracil for alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Meta-analysis of propylthiouracil for alcoholic liver disease--a Cochrane Hepato-Biliary Group Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002800.PUB3

Liver hypermetabolic state after chronic ethanol consumption: hormonal interrelations and pathogenic implications

21 January 2018

1 reference

12 December 2020

Long-term histological evaluation of the natural history and prognostic factors of alcoholic liver disease

1 reference

12 December 2020

Effect of antithyroid drugs on hydroxyl radical formation and alpha-1-proteinase inhibitor inactivation by neutrophils: therapeutic implications

1 reference

12 December 2020

Effect of propylthiouracil on the ethanol-induced increase in liver oxygen consumption in awake rats.

1 reference

12 December 2020

The swift increase in alcohol metabolism. Inhibition by propylthiouracil

1 reference

12 December 2020

Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study

1 reference

12 December 2020

Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease

1 reference

12 December 2020

Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease

1 reference

12 December 2020

Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis

1 reference

12 December 2020

Milk thistle (Silybum marianum) for the therapy of liver disease

1 reference

12 December 2020

Testosterone and alcoholic cirrhosis. Epidemiologic, pathophysiologic and therapeutic studies in men.

1 reference

12 December 2020

Hepatic vein oxygenation, liver blood flow, and the rate of ethanol metabolism in recently abstinent alcoholic patients

1 reference

12 December 2020

Long-term treatment of alcoholic liver disease with propylthiouracil

1 reference

12 December 2020

Propylthiouracil-induced fulminant hepatitis: case report and review of the literature

1 reference

12 December 2020

Increased plasma interleukin-8 concentrations in alcoholic hepatitis

1 reference

12 December 2020

Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone

1 reference

12 December 2020

Thyroid hormones in alcoholic liver disease. Effect of treatment with 6-n-propylthiouracil

1 reference

12 December 2020

Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: a randomized controlled trial

1 reference

12 December 2020

Propylthiouracil treatment for alcoholic hepatitis: the case of the missing thirty

1 reference

12 December 2020

Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration

1 reference

12 December 2020

Effect of propylthiouracil on liver cell development in the male albino mouse: protective effect against ethanol-induced alterations

1 reference

12 December 2020

Inhibitory effects of antithyroid drugs on oxygen radical formation in human neutrophils

1 reference

12 December 2020

Hepatitis B and hepatitis C virus infection among chronic alcoholic patients with liver disease in Taiwan.

1 reference

12 December 2020

10.1002/14651858.CD002800.PUB3

Identifiers

DOI

0 references

Fatcat ID

release_u2yt43d3ivfovfscireryjzti4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/u2yt43d3ivfovfscireryjzti4

24 November 2022